Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

M. de Weers, Y-T Tai, M.S. van der Veer, J.M. Bakker, T. Vink, D.C.H. Jacobs, L.A. Oomen, M. Peipp, T. Valerius, J.W. Slootstra, T. Mutis, W.K. Bleeker, K.C. Anderson, H.M. Lokhorst, J.G.J. van de Winkel, P.W.H.I. Parren

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1840-1848
Number of pages9
JournalJournal of Immunology
Volume186
Issue number3
Publication statusPublished - 2011

Cite this